Clinicians’ Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19

PURPOSE: This study investigated why some clinicians switched growth hormone (GH) brands in pediatric patients with GH-related disorders to Norditropin(®) since the start of the COVID-19 pandemic, the clinicians’ perceptions of the results, and whether observations from this period of disruption cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Joanne, Warth, Kelly, Suvarna, Yashasvi, Cappa, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464361/
https://www.ncbi.nlm.nih.gov/pubmed/34584405
http://dx.doi.org/10.2147/PPA.S325914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464361/
https://www.ncbi.nlm.nih.gov/pubmed/34584405
http://dx.doi.org/10.2147/PPA.S325914

Ejemplares similares